Page 1592 - Markets News

Piramal Enterprises dips 10%, hits 52-week low post March quarter results

The stock has fallen below its previous low of Rs 1,688, touched on May 27, 2021

Page Industries gains 8% on strong operational performance in March quarter

The company said that the sales momentum picked up significantly across all product categories backed by expansion in portfolio and existing network.

Muthoot Finance sinks 9% on weak Q4 result; analysts bearish on stock

Motilal Oswal Financial Services believes FY23 will be a difficult year for Muthoot with a clear trade-off between growth and margin

Stocks to Watch: Hindalco, Muthoot Finance, Bharti Airtel, Sun Pharma, HDFC

Stocks to Watch today: JSW Steel, FSN E-Commerce Ventures (Nykaa), Jubilant Pharma, GAIL, Glenmark Pharma, Godrej Industries, PB Fintech (Policy Bazaar) will be in focus ahead of their Q4 results.

Here's why Mehul Kothari recommends buying Balkrishna Inds, HDFC Life

According to the technical analyst from Anand Rathi, Balkrishna Industries is showing immense strength on the 2-hour chart, while the weekly chart of HDFC Life indicates a sharp up move.

Sensex halts 3-day decline, rebounds over 500 points amid F&O expiry

On similar lines, the broader NSE Nifty gained 144.35 points or 0.90 per cent to end at 16,170.15

Market strategy: Buy in the dip or sell when the markets rally?

Despite several attempts, the indices have succumbed to global and domestic cues. Should you use the current market fall to buy for long term? Are the markets discounting the rate hikes by the RBI?

Markets set to witness biggest May decline since 2012 amid FPI sell-off

So far this month, the benchmark Sensex and the Nifty indices are down 5 per cent

Here is why CLSA expects Tata Motors' stock to outperform going ahead

Tata Motors: CLSA expects a sharp uptick in volume in FY24 driven by a strong order backlog

Market strategy: Time to buy, sell or hold stocks? Here's what analysts say

Timing the markets to catch a low, analysts caution, will not be a wise strategy at the current levels given the slew of domestic and global developments over the next few weeks

'Realty mkt sees 28 land deals comprising over 1,200 acres so far this yr'

Real estate market has witnessed at least 28 land deals, including outright purchases and joint ventures, so far this year comprising over 1,200 acres, according to property consultant Anarock.

F&O expiry: Sensex up 503 pts to end atop 54K; Nifty drops 6% in May series

CLOSING BELL: The S&P BSE Sensex traded in a broad range of 921 points on Thursday as it hit a high and low of 54,346 and 53,425, respectively

ITC trades flat as stock turns ex-date for dividend of Rs 6.25 per share

ITC said the dividend will be paid between July 22, 2022 and July 26, 2022 to entitled members.

Balrampur Chini snaps 3-day losing streak; stock gains 5% on heavy volumes

Analysts believe that the government's curb on 10 metric ton sugar exports would not cause a major impact as their expectation was lower than the limit for this year.

Balrampur Chini, Shree Renuka, Triveni: Sugar stocks dip after 300% surge

Select sugar stocks like Balrampur Chini, Dwarikesh Sugar and Renuka had jumped up to 6-fold post the Covid-19 decline; However, off late the stocks have corrected sharply post export limitations.

Nifty Next 50 index hits 52-week low; SAIL, Vedanta down 27% in a month

In the past one month, Nifty Next 50 index was down 14%, as compared to 7% decline in the Nifty 50 index.

IndiGo soars 10% as CEO eyes 'profitability' after Rs 1,681 cr loss in Q4

Going forward, analysts are cautiously optimistic on the prospects of the airline as it manages demand revival amid increased competition

Sequent Scientific tanks 17% on weak Q4; stock down 70% from 52-wk high

The company said the macro environment continues to be challenging due to volatility in costs and disruptions across supply chains.

AIA Engineering gains 6% post March quarter results

In Q4 EBITDA margin improved 182 basis points (bps) YoY and 21 bps sequentially at 24.2 per cent.

Torrent Pharma rallies 9% on 1:1 bonus issue plan, dividend of Rs 23/share

In Q4, the company posted net loss of Rs 118 crore against profit of Rs 324 crore in the year ago quarter